New genetic insights into developmental dysplasia of the hip
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jun-2026 09:16 ET (1-Jun-2026 13:16 GMT/UTC)
Artificial intelligence (AI) is rapidly transforming heart failure (HF) management, offering advances from early risk prediction to treatment and continuous monitoring. A recent review led by Professor Yi-Da Tang highlights how AI integrates electronic health records, multimodal imaging, and wearable technologies to enable personalized HF care. While challenges in generalizability, interpretability, and reliability remain, ongoing innovation and validation efforts are expected to accelerate clinical translation and improve outcomes for HF patients.
Sox9, a master regulator of cartilage formation, switches its target genes dynamically during embryonic limb development instead of following a fixed program, as reported by researchers from Science Tokyo. They analyzed mouse embryonic forelimb cells across different developmental stages using single-cell-level gene expression analysis and a state-of-the-art technique to detect Sox9’s DNA binding sites. The findings lay the foundation for future research on skeletal diseases and regenerative medicine.
Integrating mechanobiological principles into disease pathogenesis, therapeutic development, and tissue engineering is reshaping our understanding of biological systems and accelerating the advancement of mechanotherapy and mechanohealth. This field reveals how mechanical cues regulate cellular behavior, such as force transmission along integrin-nucleus pathways and collective cell migration, and tissue functions. In doing so, mechanobiology connects fundamental research with clinical applications, from limiting cancer metastasis and fibrosis to promoting bone regeneration and maintaining vascular homeostasis. Building on discussion from the Inaugural International Conference on Mechanobiology (ICM) 2025, integrating mechanobiological research with clinical strategies offers new opportunities to address unmet needs, including personalized anti-fibrotic interventions or precision bone regenerative therapies. At the same time, it supports the broader concept of mechanohealth -- a paradigm focused on preserving the physiological mechanical balance within tissues.
Investigators from VHIO, which is part of the Vall Hebron Campus, publish the first study to address the impact of the exposome on early-onset colorectal cancer through epigenetic signatures.
The researchers compared epigenetic methylation marks in patients with early-onset colorectal cancer with those of patients with late-onset colorectal cancer and confirmed previously identified risk factors including diet, education level, and smoking.
They have now identified exposure to picloram, a widely used herbicide, as a new risk factor associated with the development of colorectal cancer in individuals younger than 50 years old. Using population data, the investigators report that US counties with a higher use of this pesticide have higher rates of early-onset colorectal cancer, even after accounting for socioeconomic factors and the use of other pesticides.
Published today in Nature Medicine, this research has been possible thanks to the funding received from the "la Caixa" Foundation and the Spanish Association Against Cancer.
The UCI Health Regional Burn Center is one of the only burn centers in Orange County equipped to treat the most complex burn patients 24 hours a day, including children.
Orange County is not unique in that such centers are few and far between. That is a major problem, say experts in a review paper co-authored by Dr. James C. Jeng, a trauma, burn and critical care surgeon at UCI Health.